Scientists target new biomarkers for Alzheimer's, immune system health and colon cancer;

> UT Southwestern Medical Center scientists have helped develop a novel technology to diagnose Alzheimer's disease from blood samples long before symptoms appear. This preliminary technology, which uses synthetic molecules to seek out and identify disease-specific antibodies, also could be used eventually in the development of specific biomarkers for a range of other hard-to-diagnose diseases and conditions, including Parkinson's disease and immune system-related diseases like multiple sclerosis and lupus, the researchers predict. Release

> Investigators at Stanford have set out to find a common biomarker that can be used to assess the health of the human immune system. Story

> Micromedic Technologies is engaged in a clinical trial designed to find biomarkers for early-stage colon cancer. Report

> A new Indo-US Cancer Prevention and Biomarker workshop has been inaugurated to help target drugs where they will be most effective. Story

> Luminex Corporation has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays.  Release

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.